Latest Ai Platforms News

Alcidion Group Limited has reported a record FY25 with strong revenue growth, major NHS contract wins, and expanded AI capabilities in its Miya Precision platform, setting the stage for global healthcare IT expansion.

SenSen Networks reported a record first quarter for FY26 with $4.3 million in cash receipts and positive operating cashflow, driven by new contracts across Singapore, the USA, and Australia. The company’s AI platform SenDISA continues to expand its footprint in Smart City solutions.

Hiremii Group has successfully raised $650,000 through an oversubscribed placement, underscoring strong investor confidence as it pushes forward with commercialising its AI-driven recruitment platform.

Horizon Gold reports significant gold intercepts from water bore drilling at its Gum Creek Project and launches an AI-powered exploration partnership to accelerate resource growth.

Artrya Limited has successfully completed a strongly supported Share Purchase Plan, raising approximately A$5 million despite significant oversubscription. This follows a recent $75 million placement, underscoring investor confidence in its AI-driven coronary artery disease platform.

Algorae Pharmaceuticals has secured an exclusive licensing agreement with Sakar Healthcare to introduce five generic oncology medicines in Australia and New Zealand, marking its first commercial foray in the region.

Pathkey.AI has upgraded its TrialKey platform to include drug-level molecular and pharmacokinetic features, enhancing clinical trial predictions and opening doors to AI-driven drug discovery.

dorsaVi has achieved a major engineering milestone by validating its RRAM-powered Reflex Platform, delivering neural reflex decisions in under one microsecond with ultra-low energy consumption. This breakthrough paves the way for next-generation robotics, prosthetics, and wearable devices that require rapid, energy-efficient reflex actions.

InteliCare Holdings has raised $2 million through a two-tranche placement to accelerate its AI-driven aged care platform and terminated a convertible note facility to streamline its capital base.

Artrya Limited has raised A$75 million through a two-tranche placement and launched a A$5 million share purchase plan to fast-track the U.S. commercialisation of its AI-powered Salix platform following FDA clearance.

SenSen Networks has secured $2 million in new contracts across Singapore, the USA, and Australia, reinforcing its position as a leader in Live Awareness AI solutions. The company also strengthened its balance sheet with $1.5 million cash received from a recent Montreal project.

SenSen Networks has reported a strong financial turnaround in FY2025, driven by rapid expansion in North America and innovative AI kerb enforcement technology. The company’s improved margins and positive cash flow signal a promising outlook for its Smart Cities strategy.